We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 1,330 results
  1. Trypanosoma brucei brucei Induced Hypoglycaemia Depletes Hepatic Glycogen and Altered Hepatic Hexokinase and Glucokinase Activities in Infected Mice

    Purpose

    Little progress has been made in understanding the effect of Trypanosoma brucei brucei infection that was allowed to run its course without...

    Rotimi Johnson Ojo, Grace Manmak Paul, ... Gideon Gyebi in Acta Parasitologica
    Article 27 April 2022
  2. Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus

    Glucokinase (GK) is an enzyme involved in synthesising glucose into glucose-6 phosphate and serves a crucial function in glucose sensing. Therefore,...

    Altaf Khan, Aziz Unnisa, ... Sharuk Khan in In Silico Pharmacology
    Article 02 December 2021
  3. Design and synthesis of newer N-benzimidazol-2yl benzamide analogues as allosteric activators of human glucokinase

    Allosteric activators of human glucokinase (GK) had revealed significant hypoglycemic effects for therapy of type-2 diabetes (T2D) in animal as well...

    Sukhbir Singh, Sandeep Arora, ... Ajmer Singh Grewal in Medicinal Chemistry Research
    Article 13 January 2021
  4. Involvement of Nitric Oxide in Insulin Secretion to Carbohydrate Metabolism

    Since the discovery of nitric oxide (NO) as an important mediator of vasoregulation, the molecule has been found to be involved in several...
    Somanjana Khatua, Sarbashri Bank, Krishnendu Acharya in Nitric Oxide: From Research to Therapeutics
    Chapter 2023
  5. Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

    Improving glucose sensitivity remains an unmet medical need in treating type 2 diabetes (T2D). Dorzagliatin is a dual-acting, orally bioavailable...

    Dalong Zhu, Xiaoying Li, ... Li Chen in Nature Medicine
    Article 12 May 2022
  6. Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

    Metformin, the first-line therapy for type 2 diabetes (T2D), decreases hepatic glucose production and reduces fasting plasma glucose levels....

    Wenying Yang, Dalong Zhu, ... Li Chen in Nature Medicine
    Article Open access 12 May 2022
  7. Antidiabetic potential of Chromolaena Odorata leave extract and its effect on Nrf2/keap1 antioxidant pathway in the liver of diabetic-induced Wistar Rats

    The incidence of liver dysfunction increases in diabetes due to insulin resistance and oxidative stress. Chromolaena odorata is a dominant medicinal...

    Olusola Olalekan Elekofehinti, Nicholas Adeyemi Adewumi, Opeyemi Iwaloye in Advances in Traditional Medicine
    Article 26 October 2021
  8. Involvement of the vagus nerve and hepatic gene expression in serum adiponectin concentrations in mice

    Several humoral factors, such as adiponectin and urate, have been suggested to affect metabolic syndromes. Previously, we reported a reduction in...

    Naoto Hashimoto, Ryuji Nagata, ... Michihiro Fukushima in Journal of Physiology and Biochemistry
    Article 14 October 2023
  9. Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease

    Objective

    GCK rs780094 polymorphism is a single nucleotide polymorphism that has been associated with obesity, type II diabetes and dyslipidemia in...

    Saba Mohammadi, Safar Farajnia, ... Roghayyeh Baghban in BMC Research Notes
    Article Open access 10 January 2020
  10. FiTMuSiC: leveraging structural and (co)evolutionary data for protein fitness prediction

    Systematically predicting the effects of mutations on protein fitness is essential for the understanding of genetic diseases. Indeed, predictions...

    Matsvei Tsishyn, Gabriel Cia, ... Fabrizio Pucci in Human Genomics
    Article Open access 16 April 2024
  11. Sex Dimorphic Glucose Transporter-2 Regulation of Hypothalamic Astrocyte Glucose and Energy Sensor Expression and Glycogen Metabolism

    The plasma membrane glucose transporter-2 (GLUT2) monitors brain cell uptake of the critical nutrient glucose, and functions within astrocytes of...

    Madhu Babu Pasula, Prabhat R. Napit, ... Karen P. Briski in Neurochemical Research
    Article 29 September 2022
  12. Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea

    Backgrounds

    Metabolic dysfunction-associated steatotic liver disease (MASLD) has gained attention owing to its severe complications. This study aimed...

    Yu-Jin Kwon, Ja-Eun Choi, ... Ji-Won Lee in Journal of Translational Medicine
    Article Open access 25 June 2024
  13. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease

    Nonalcoholic fatty liver disease (NAFLD) is common and partially heritable and has no effective treatments. We carried out a genome-wide association...

    Yanhua Chen, Xiaomeng Du, ... Elizabeth K. Speliotes in Nature Genetics
    Article 14 September 2023
  14. Anti-diabetes Research in India: Contributions from Industrial Organizations

    The various aspects of past, present, and future of anti-diabetes research in India are covered here. A brief introduction on prevalence of diabetes...
    Sarbani Pal, Manojit Pal in Drug Discovery and Drug Development
    Chapter 2021
  15. Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia

    Glucokinase-maturity-onset diabetes of the young (GCK-MODY or MODY 2), caused by a heterozygous inactivating variant in the Glucokinase ( GCK) gene,...

    Kok-Siong Poon, Karen Mei-Ling Tan, ... Andrew Sng in Human Genome Variation
    Article Open access 30 March 2020
  16. A structural model of glucose regulation for building prognostic algorithms for controlling insulin therapy

    This work discusses the physiological processes influencing the dynamics of blood glucose concentration in patients with diabetes mellitus and...

    É. I. Strukova, K. V. Pozhar in Biomedical Engineering
    Article 08 May 2024
  17. Linking Variants of Hemoglobin A1C and Glycemic Status

    Hemoglobin A1C (HbA1c) has been used as a convenient screening test for the diagnosis of diabetes and prediabetes, requiring no fasting, as well as a...
    Jee-Young Moon, Qibin Qi in Biomarkers in Diabetes
    Reference work entry 2023
  18. The emergence of sulfo-click amidation in kinetic target-guided synthesis

    Sulfo-click is a chemoselective and biocompatible reaction between thioacids and sulfonyl azides that forms highly versatile N -acylsulfonamides,...

    Prakash T. Parvatkar, Roman Manetsch in Medicinal Chemistry Research
    Article Open access 18 May 2024
  19. Genome Editing and Fatty Liver

    Fatty liver disease is characterized as nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). Fatty liver disease is one of the...
    Umar Hayat, Ali A. Siddiqui, ... Nasir Hameed in Genome Editing in Cardiovascular and Metabolic Diseases
    Chapter 2023
  20. Interaction between the GCKR rs1260326 variant and serum HDL cholesterol contributes to HOMA-β and ISIMatusda in the middle-aged T2D individuals

    This study aims to investigate the correlations between islet function/ insulin resistance and serum lipid levels, as well as to assess whether the...

    Min Shen, Liying Jiang, ... Kuanfeng Xu in Journal of Human Genetics
    Article 31 August 2023
Did you find what you were looking for? Share feedback.